Open AccessSuboptimal Dosing of β-Blockers in Chronic Heart Failure
Author(s) -
Melanie McGinlay,
Sam Straw,
R Byrom-Goulthorp,
Samuel D. Relton,
John Gierula,
Richard M Cubbon,
Mark T. Kearney,
Klaus K. Witte
Publication year - 2021
Publication title -
journal of cardiovascular nursing/the journal of cardiovascular nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 59
eISSN - 1550-5049
pISSN - 0889-4655
DOI - 10.1097/jcn.0000000000000847
Subject(s) - medicine , dosing , contraindication , heart failure , bisoprolol , blood pressure , ejection fraction , cardiology , heart rate , prospective cohort study , alternative medicine , pathology
The evidence base for the benefits of β-blockers in heart failure with reduced ejection fraction (HFrEF) suggests that higher doses are associated with better outcomes.